SELLAS Life Sciences (SLS) Interest & Investment Income (2010 - 2013)
SELLAS Life Sciences' (SLS) quarterly Interest & Investment Income came in at -$2.6 million in Q4 2013, down 130200.0% year-on-year from N/an in Q4 2012, and down 23.43% on a QoQ basis from -$2.1 million in Q3 2013.
SELLAS Life Sciences (SLS) Interest & Investment Income (2010 - 2013) Analysis & Trends
SELLAS Life Sciences (SLS) has 4 years of Interest & Investment Income data on file, last reported at -$2.6 million in Q4 2013.
- On a quarterly basis, Interest & Investment Income fell 130200.0% year-over-year to -$2.6 million in Q4 2013; TTM through Sep 2014 was -$4.7 million, a 362.1% decrease from a year earlier, with the FY2016 full-year figure at -$3.5 million, down 361.58% from the prior year.
- Interest & Investment Income for Q4 2013 stood at -$2.6 million, down from -$2.1 million in the prior quarter.
- Over the last five years, Interest & Investment Income for SLS reached as high as $7.0 million in Q1 2013 and fell as low as -$3.1 million in Q2 2013.
- Historically, Interest & Investment Income has averaged -$70333.3 across 4 years, with a median of -$2500.0 in 2011.
- On a YoY basis, Interest & Investment Income climbed as much as 44043.75% in 2013 and fell as far as 130200.0% in 2013.
- Year by year, Interest & Investment Income stood at $3000.0 in 2010, then sank by 133.33% to -$1000.0 in 2011, then soared by 300.0% to $2000.0 in 2012, then sank by 130200.0% to -$2.6 million in 2013.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$2.6 million in Q4 2013, -$2.1 million in Q3 2013, and -$3.1 million in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | SELLAS Life Sciences | 1.89 Bn | 1.78 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -2.60 Mn |
| Sep 30, 2013 | -2.11 Mn |
| Jun 30, 2013 | -3.13 Mn |
| Mar 31, 2013 | 7.03 Mn |
| Dec 31, 2012 | 2,000.00 |
| Jun 30, 2012 | -19,000.00 |
| Mar 31, 2012 | -16,000.00 |
| Dec 31, 2011 | -1,000.00 |
| Sep 30, 2011 | -2,000.00 |
| Jun 30, 2011 | -3,000.00 |
| Mar 31, 2011 | -1,000.00 |
| Sep 30, 2010 | 3,000.00 |